Raymond James cuts CVS Health stock price target on split valuation
Raymond James reduced its price target for CVS Health (NYSE:CVS) to $103 from $120, maintaining an Outperform rating. The stock is currently at $81.33. The firm applied a sum-of-the-parts valuation following CVS's plan to split its retail drugstore business. CVS reported strong Q3 2026 earnings, exceeding expectations, but its stock declined in premarket trading due to the planned breakup. The company raised its full-year 2026 adjusted EPS and revenue guidance.
How this was made
The 30-second read
Why it matters
Analyst price‑target cut reflects concerns over valuation of the combined company and execution risk of the spinoff.
Market read
The downgrade and split announcement provide a near‑term catalyst for CVS stock, with potential broader implications for health‑care sector valuations.
What to watch
Potential cost synergies and a clearer focus for each entity may improve long‑term earnings beyond the short‑term price pressure.
Background
CVS Health announced a plan to separate its retail pharmacy business from its insurance and PBM operations, targeting a 2028 completion.
Ticker impact
Raymond James lowered CVS Health's price target to $103 from $120 after the company announced a split of its retail pharmacy business.
likely pressure as the market prices in the lower target and uncertainty around the spinoff.
The new target is 20% below the prior level and the split creates valuation uncertainty for both entities.
Market effects
The split could prompt re‑rating of other integrated health‑care retailers and insurers.
U.S. health‑care sector may see modest rebalancing as investors assess split‑related exposure.
Limited to U.S. markets; no immediate global ripple.
Counterpoint
The split could unlock value in the retail pharmacy unit, offering a buying opportunity despite the lower target.
Key entities
- AnalystRaymond James
Equity research firm that revised CVS price target.
- CompanyCVS Health
U.S. health‑care retailer and insurer undergoing a split.
